BioScrip (NASDAQ: BIOS ) is to float a 12.5 million-strong offering of its common stock in an underwritten public offering. That amount includes 3.125 million shares being offered by selling stockholders. The price has been set at $12.00 per share. Additionally, the company's underwriters have been granted a 30-day purchase option for up to an additional 1.875 million shares.
BioScrip estimates it will reap proceeds of roughly $106.5 million, and will use the monies for "general corporate purposes." It will not take in any proceeds from the shares offered by the selling stockholders.